About Porter Pharmaceutical Services
PorterPharma was founded in 2007 by Kaela M. Porter. Ms. Porter has nearly 20 years of drug development experience encompassing small molecule, biologic and device development at CRO, biotechnology, drug delivery and specialty pharma companies. Ms. Porter began her career at Arthur D. Little's Life Sciences Division in Cambridge, MA. Following five years of performing contract research in the PK/ADME group at ADL, Ms. Porter moved to Biogen, Inc., also in Cambridge's Kendall Square. As a scientist in the Preclinical Development group at Biogen, Ms. Porter was involved in both small molecule and biologic development teams in a variety of indications, including auto-immune, cardiovascular and oncology programs. Drug delivery, candidate screening & selection, clinical study design and pharmacokinetics were Ms. Porter's focus at Emisphere Technologies, Inc. in Tarrytown, NY. Prior to founding PorterPharma, Ms. Porter held the position of Senior Pharmacokineticist at Penwest Pharmaceutical Co., in Danbury, CT, a specialty pharma company developing compounds to treat pain, CNS, cardiovascular and mitochondrial diseases.
PorterPharma also works on a case-by-case basis with a number of industry professionals, including pharmacokineticists, pharmacologists, statisticians, regulatory specialists, clinicians and clinical operations specialists.
Our clients include specialty pharma and biotechnology companies, contract research organizations and site management organizations, non-profit organizataion and clinical and regulatory consulting firms in the US and Canada. Projects have been as diverse as document management, SOP generation and website review, to PK/PD modeling, preclinical ADME study review and IND filing.
Click the link for a copy of Ms. Porter's CV.